1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, 2023–2031
5. Key Insights
5.1. Applications of real-time PCR in the continuum of care and patient management.
5.2. Strengths of dPCR and qPCR
5.3. Key product/brand Analysis
5.4. Technological Advancements
5.5. Top 3 players operating in the market space
5.6. COVID Impact Analysis
6. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2023–2031
6.3.1. Quantitative PCR
6.3.1.1. Reagents & Consumables
6.3.1.2. Instruments
6.3.1.3. Software
6.3.2. Digital PCR
6.3.2.1. Reagents & Consumables
6.3.2.2. Instruments
6.3.2.3. Software
6.4. Market Attractiveness Analysis, by Product Type
7. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2023–2031
7.3.1. Clinical Applications
7.3.2. Research Applications
7.3.3. Pathogen Testing
7.3.4. Oncology Testing
7.3.5. Blood Screening
7.3.6. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2023–2031
8.3.1. Hospitals & Diagnostic Centers
8.3.2. Research Laboratories & Academic Institutes
8.3.3. Pharmaceutical & Biotechnology Companies
8.3.4. Clinical Research Organizations
8.3.5. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2023–2031
10.2.1. Quantitative PCR
10.2.1.1. Reagents & Consumables
10.2.1.2. Instruments
10.2.1.3. Software
10.2.2. Digital PCR
10.2.2.1. Reagents & Consumables
10.2.2.2. Instruments
10.2.2.3. Software
10.3. Market Value Forecast, by Application, 2023–2031
10.3.1. Clinical Applications
10.3.2. Research Applications
10.3.3. Pathogen Testing
10.3.4. Oncology Testing
10.3.5. Blood Screening
10.3.6. Others
10.4. Market Value Forecast, by End-user, 2023–2031
10.4.1. Hospitals & Diagnostic Centers
10.4.2. Research Laboratories & Academic Institutes
10.4.3. Pharmaceutical & Biotechnology Companies
10.4.4. Clinical Research Organizations
10.4.5. Others
10.5. Market Value Forecast, by Country, 2023–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2023–2031
11.2.1. Quantitative PCR
11.2.1.1. Reagents & Consumables
11.2.1.2. Instruments
11.2.1.3. Software
11.2.2. Digital PCR
11.2.2.1. Reagents & Consumables
11.2.2.2. Instruments
11.2.2.3. Software
11.3. Market Value Forecast, by Application, 2023–2031
11.3.1. Clinical Applications
11.3.2. Research Applications
11.3.3. Pathogen Testing
11.3.4. Oncology Testing
11.3.5. Blood Screening
11.3.6. Others
11.4. Market Value Forecast, by End-user, 2023–2031
11.4.1. Hospitals & Diagnostic Centers
11.4.2. Research Laboratories & Academic Institutes
11.4.3. Pharmaceutical & Biotechnology Companies
11.4.4. Clinical Research Organizations
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2023–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2023–2031
12.2.1. Quantitative PCR
12.2.1.1. Reagents & Consumables
12.2.1.2. Instruments
12.2.1.3. Software
12.2.2. Digital PCR
12.2.2.1. Reagents & Consumables
12.2.2.2. Instruments
12.2.2.3. Software
12.3. Market Value Forecast, by Application, 2023–2031
12.3.1. Clinical Applications
12.3.2. Research Applications
12.3.3. Pathogen Testing
12.3.4. Oncology Testing
12.3.5. Blood Screening
12.3.6. Others
12.4. Market Value Forecast, by End-user, 2023–2031
12.4.1. Hospitals & Diagnostic Centers
12.4.2. Research Laboratories & Academic Institutes
12.4.3. Pharmaceutical & Biotechnology Companies
12.4.4. Clinical Research Organizations
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2023–2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2023–2031
13.2.1. Quantitative PCR
13.2.1.1. Reagents & Consumables
13.2.1.2. Instruments
13.2.1.3. Software
13.2.2. Digital PCR
13.2.2.1. Reagents & Consumables
13.2.2.2. Instruments
13.2.2.3. Software
13.3. Market Value Forecast, by Application, 2023–2031
13.3.1. Clinical Applications
13.3.2. Research Applications
13.3.3. Pathogen Testing
13.3.4. Oncology Testing
13.3.5. Blood Screening
13.3.6. Others
13.4. Market Value Forecast, by End-user, 2023–2031
13.4.1. Hospitals & Diagnostic Centers
13.4.2. Research Laboratories & Academic Institutes
13.4.3. Pharmaceutical & Biotechnology Companies
13.4.4. Clinical Research Organizations
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2023–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2023–2031
14.2.1. Quantitative PCR
14.2.1.1. Reagents & Consumables
14.2.1.2. Instruments
14.2.1.3. Software
14.2.2. Digital PCR
14.2.2.1. Reagents & Consumables
14.2.2.2. Instruments
14.2.2.3. Software
14.3. Market Value Forecast, by Application, 2023–2031
14.3.1. Clinical Applications
14.3.2. Research Applications
14.3.3. Pathogen Testing
14.3.4. Oncology Testing
14.3.5. Blood Screening
14.3.6. Others
14.4. Market Value Forecast, by End-user, 2023–2031
14.4.1. Hospitals & Diagnostic Centers
14.4.2. Research Laboratories & Academic Institutes
14.4.3. Pharmaceutical & Biotechnology Companies
14.4.4. Clinical Research Organizations
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2023–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company (2021)
15.3. Company Profiles
15.3.1. Bio Rad Laboratories
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Thermo Fisher Scientific, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Qiagen
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. F. Hoffmann La Roche Ltd.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Abbott Laboratories
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Agilent Technologies
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. BD
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Danaher Corporation
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Merck KGaA
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Takara Bio, Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer